High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$53.2M
$53,179,002
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-03-11 | $21,392 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2026-03-11
$102,300
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-03-11 | $102,300 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-03-11 | $15,585 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-03-11 | $28,372 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-02-04 | $97,624 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-02-04 | $78,879 | M | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Other
2026-02-04
$141,218
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-02-04 | $141,218 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2026-02-04
$348,600
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-02-04 | $348,600 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 SellΔOwn -40.0%
2026-02-04
$231,597
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 SellΔOwn -40.0%
|
2026-02-04 | $231,597 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2026-01-07
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2026-01-07
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-01-07 | $56,743 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-01-07 | $39,283 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2026-01-07 | $31,170 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2026-01-07
$220,289
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-01-07 | $220,289 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2026-01-07
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-16 | $12,210 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -98.0%
|
2025-12-16 | $600,507 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -38.4%
|
2025-12-16 | $381,685 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -62.5%
|
2025-12-16 | $1,652,855Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -15.8%
|
2025-12-16 | $495,013 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2025-12-16 | $774,699 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-16 | $457,097 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -41.9%
|
2025-12-16 | $2,261,492Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-16 | $180,586 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-16 | $564,597 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $1,931,331Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $540,127 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $575,629 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $1,774,160Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $1,203,867Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $1,516,335Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $1,573,168Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -20.2%
|
2025-12-15 | $4,368,018Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -19.0%
|
2025-12-15 | $3,294,798Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -36.0%
|
2025-12-15 | $5,066,489Whale | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $729,749 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $37,743 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $291,256 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-12-15 | $376,009 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-12-11 | $19,641 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-12-11 | $15,585 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-12-11
$107,900
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-12-11 | $107,900 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-11
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-11
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-11
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-12-11 | $28,372 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-12-10
$105,669
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-12-10 | $105,669 | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-10
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-12-10 | $19,641 | M | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-10
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Equity Compensation
2025-12-10
$0
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Equity Compensation
|
2025-12-10 | $0 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-12-10 | $28,372 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-12-10 | $15,585 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Sanders Corazon (Corsee) D.
• Director
Discretionary SellΔOwn -69.4%
2025-11-26
$620,185
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Director
Discretionary SellΔOwn -69.4%
|
2025-11-26 | $620,185 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Director
Other
|
2025-11-26 | $417,772 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Sanders Corazon (Corsee) D.
• Director
Discretionary Sell
2025-11-26
$275,349
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Director
Discretionary Sell
|
2025-11-26 | $275,349 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Director
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Wu Xiaobin
• COO
Discretionary SellΔOwn -79.0%
2025-11-17
$1,199,617Large
|
||||||
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary SellΔOwn -79.0%
|
2025-11-17 | $1,199,617Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary SellΔOwn -98.8%
|
2025-11-17 | $314,862 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-17 | $3,823 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-13 | $674,077 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Wu Xiaobin
• COO
Discretionary SellΔOwn -70.6%
2025-11-13
$1,612,583Large
|
||||||
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary SellΔOwn -70.6%
|
2025-11-13 | $1,612,583Large | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 SellΔOwn -66.7%
2025-11-12
$231,570
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 SellΔOwn -66.7%
|
2025-11-12 | $231,570 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-11-12
$116,200
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-11-12 | $116,200 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Wu Xiaobin
• COO
Discretionary SellΔOwn -44.0%
2025-11-12
$1,745,024Large
|
||||||
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary SellΔOwn -44.0%
|
2025-11-12 | $1,745,024Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-12 | $55,759 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-11-12 | $58,730 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-11-12 | $84,901 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-11-12 | $47,073 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-12 | $35,743 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-12 | $42,600 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-12 | $88,903 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-12 | $278,341 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Wu Xiaobin
• COO
Discretionary SellΔOwn -20.9%
2025-11-12
$1,138,569Large
|
||||||
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary SellΔOwn -20.9%
|
2025-11-12 | $1,138,569Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
COO
Discretionary Sell
|
2025-11-12 | $175,220 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-10-08
$230,952
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-10-08 | $230,952 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 SellΔOwn -53.2%
2025-10-08
$1,657,580Large
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 SellΔOwn -53.2%
|
2025-10-08 | $1,657,580Large | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-10-08
$1,461,375Large
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-10-08 | $1,461,375Large | S | Form 4 |
|
ONC
M
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
Other
2025-10-08
$1,911,561Large
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-10-08 | $1,911,561Large | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-10-08 | $58,730 | M | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-10-08
$389,200
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-10-08 | $389,200 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
Other
|
2025-10-08 | $47,073 | M | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -29.0%
|
2025-09-16 | $2,237,402Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -90.9%
|
2025-09-16 | $1,310,227Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 Sell
|
2025-09-16 | $131,112 | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -14.6%
|
2025-09-16 | $1,317,862Large | S | Form 4 |
| ONC |
BeOne Medicines Ltd.
|
CEO
10b5-1 SellΔOwn -73.8%
|
2025-09-16 | $4,059,091Large | S | Form 4 |